DiaCarta
DiaCarta, Hopkins MedTech Partner to Offer LDT and IVD Validation Services
The companies aim to fill an unmet need by shepherding diagnostic companies through regulatory and clinical lab validation processes.
DiaCarta SPAC Merger Scuttled on Allegations of Wrongdoing
DiaCarta said it received notice that special purpose acquisition company HH&L Acquisition was ending the business combination agreement signed in October 2022.
In Brief This Week: Thermo Fisher Scientific, Danaher, Accelerate Diagnostics, Oncocyte, More
News items for the week of May 8, 2023.
DiaCarta Nabs FDA Emergency Use Authorization for Monkeypox Test
The laboratory-use QuantiVirus MPXV Test Kit targets two regions of the MPXV genome to detect the virus even if mutations occur in one target region.
DiaCarta to go Public Through SPAC Merger
The firm would join a number of biopharma and diagnostic companies that have used SPACs during the COVID-19 pandemic to tap the public markets.
Mar 23, 2020
DiaCarta SARS-CoV-2 Test Kit Receives CE Mark
Feb 12, 2018
DiaCarta Raises $45M in Series B Funding
Feb 21, 2017